Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer

Clinical trial NCT00208546 · COMPLETED

Trial details

NCT number: NCT00208546
Sponsor: Dutch Colorectal Cancer Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2005-06-01
Primary completion: 2009-07-01
Enrollment: 750

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.